Impact of Covid19 on a tertiary care pediatric oncology and stem cell transplant unit in Riyadh, Saudi Arabia.
作者信息
Ahmad Naveed, Essa Mohammed F, Sudairy Reem
机构信息
Department of Pediatric Hematology & Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia.
出版信息
Pediatr Blood Cancer. 2020 Sep;67(9):e28560. doi: 10.1002/pbc.28560. Epub 2020 Jul 12.
Abstract
摘要
相似文献
1
Impact of Covid19 on a tertiary care pediatric oncology and stem cell transplant unit in Riyadh, Saudi Arabia.新型冠状病毒肺炎对沙特阿拉伯利雅得一家三级医疗儿科肿瘤与干细胞移植科室的影响。
Pediatr Blood Cancer. 2020 Sep;67(9):e28560. doi: 10.1002/pbc.28560. Epub 2020 Jul 12.
2
Clinical, epidemiological, and laboratory characteristics of mild-to-moderate COVID-19 patients in Saudi Arabia: an observational cohort study.沙特阿拉伯轻度至中度 COVID-19 患者的临床、流行病学和实验室特征：一项观察性队列研究。
Eur J Med Res. 2020 Nov 25;25(1):61. doi: 10.1186/s40001-020-00462-x.
3
Chemotherapy adaptations in a referral tertiary care center in India for ongoing therapy of pediatric patients with solid tumors during COVID19 pandemic and lockdown.印度一家三级转诊护理中心在新冠疫情封锁期间对实体瘤儿科患者进行持续化疗的调整措施
Pediatr Blood Cancer. 2020 Nov;67(11):e28428. doi: 10.1002/pbc.28428. Epub 2020 Jul 31.
4
Reduction in the rate and improvement in the prognosis of COVID-19 in haematological patients over time.随着时间推移，血液学患者中新冠病毒病（COVID-19）的发病率降低，预后改善。
Leukemia. 2021 Feb;35(2):632-634. doi: 10.1038/s41375-020-01015-1. Epub 2020 Aug 7.
5
Leading cause of death in comparison to COVID-19 in Saudi Arabia.沙特阿拉伯与新冠病毒病相比的主要死因。
Eur Rev Med Pharmacol Sci. 2021 Mar;25(6):2468-2469. doi: 10.26355/eurrev_202103_25406.
6
Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom.英国一家大型城市医疗信托机构中血液系统恶性肿瘤合并新型冠状病毒肺炎感染住院患者的结局
Leuk Lymphoma. 2021 Feb;62(2):469-472. doi: 10.1080/10428194.2020.1838506. Epub 2020 Nov 9.
7
Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era?在新冠疫情时代，是否需要重新考虑在异基因造血细胞移植后使用 G-CSF？
Br J Cancer. 2021 Mar;124(7):1183. doi: 10.1038/s41416-020-01195-8. Epub 2021 Jan 4.
8
Burnout in medical oncology during the COVID-19 pandemic.2019冠状病毒病大流行期间医学肿瘤学领域的职业倦怠
Expert Rev Anticancer Ther. 2021 Apr;21(4):351-353. doi: 10.1080/14737140.2021.1866549. Epub 2020 Dec 23.
9
Impact of COVID-19 on cancer patients: A review.COVID-19 对癌症患者的影响：综述。
Asia Pac J Clin Oncol. 2021 Jun;17(3):186-192. doi: 10.1111/ajco.13445. Epub 2020 Sep 24.
10
Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India.来自印度血液癌症登记处的血液系统恶性肿瘤患者与新冠病毒病的治疗结果。
Blood Cancer J. 2022 Jan 5;12(1):2. doi: 10.1038/s41408-021-00599-w.
引用本文的文献
1
Impact of the COVID-19 pandemic on physical therapy practice in Saudi Arabia.COVID-19 大流行对沙特阿拉伯物理治疗实践的影响。
PLoS One. 2022 Dec 9;17(12):e0278785. doi: 10.1371/journal.pone.0278785. eCollection 2022.
2
The impact of COVID-19 pandemic on access to treatment for children with cancer in India and treating center practices.COVID-19 大流行对印度儿童癌症治疗机会和治疗中心实践的影响。
Cancer. 2022 Feb 1;128(3):579-586. doi: 10.1002/cncr.33945. Epub 2021 Oct 7.
3
Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis.癌症合并新冠病毒肺炎的儿科患者的生存情况及并发症：一项荟萃分析
Front Oncol. 2021 Jan 21;10:608282. doi: 10.3389/fonc.2020.608282. eCollection 2020.
本文引用的文献
1
Collateral effects of COVID-19 pandemic in pediatric hematooncology: Fatalities caused by diagnostic delay.新冠疫情对儿童血液肿瘤学的附带影响：诊断延误导致的死亡病例
Pediatr Blood Cancer. 2020 Aug;67(8):e28482. doi: 10.1002/pbc.28482. Epub 2020 Jun 11.
2
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy.新冠疫情期间的癌症患儿：来自意大利伦巴第大区六个儿科肿瘤血液中心的八周报告
Pediatr Blood Cancer. 2020 Aug;67(8):e28410. doi: 10.1002/pbc.28410. Epub 2020 May 26.
3
Use of all cause mortality to quantify the consequences of covid-19 in Nembro, Lombardy: descriptive study.使用全因死亡率量化伦巴第大区内姆布罗市新冠疫情的后果：描述性研究。
BMJ. 2020 May 14;369:m1835. doi: 10.1136/bmj.m1835.
4
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy.COVID-19 和造血细胞移植面临的挑战；EBMT 关于造血细胞移植受者、供者和接受 CAR-T 细胞治疗患者管理的建议。
Bone Marrow Transplant. 2020 Nov;55(11):2071-2076. doi: 10.1038/s41409-020-0919-0. Epub 2020 May 13.
5
COVID-19 in pediatric oncology from French pediatric oncology and hematology centers: High risk of severe forms?法国儿科肿瘤学与血液学中心的儿童肿瘤学中的COVID-19：重症形式的高风险？
Pediatr Blood Cancer. 2020 Jul;67(7):e28392. doi: 10.1002/pbc.28392. Epub 2020 May 8.
6
COVID-19 infection in children and adolescents with cancer in Madrid.马德里癌症患儿及青少年的新冠病毒感染情况
Pediatr Blood Cancer. 2020 Jul;67(7):e28397. doi: 10.1002/pbc.28397. Epub 2020 May 8.
7
COVID-19 pandemic and impact on hematopoietic stem cell transplantation.2019冠状病毒病大流行及其对造血干细胞移植的影响。
Bone Marrow Transplant. 2020 Nov;55(11):2193-2195. doi: 10.1038/s41409-020-0913-6. Epub 2020 May 4.
8
Safeguarding cancer care in a post-COVID-19 world.在新冠疫情后的世界中保障癌症护理。
Lancet Oncol. 2020 May;21(5):603. doi: 10.1016/S1470-2045(20)30243-6.
9
How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review.免疫抑制状态如何影响 SARS-CoV-2 感染中的儿童和成人？系统评价。
J Infect. 2020 Jul;81(1):e61-e66. doi: 10.1016/j.jinf.2020.04.026. Epub 2020 Apr 23.
10
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
Zotero 插件